安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Mallinckrodt - Home | Introducing Keenova and Par Health
Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products Stay tuned for updates
- Mallinckrodt - Wikipedia
Mallinckrodt Mallinckrodt Pharmaceuticals plc is an Irish-American manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents [2] In 2017, it had 5,500 employees and sales of $3 2 billion, of which $2 9 billion was from the U S healthcare system [3]
- Mallinckrodt, Endo become Keenova following generics spinoff
The merger and corporate makeover represent a fresh start for Mallinckrodt and Endo, which have both faced significant financial pressure in recent years over their alleged roles in the opioid
- Irelands Mallinckrodt closes spinout, rebrands as Keenova
Now, the separation of Par leaves Keenova with the branded medicine businesses of Mallinckrodt and Endo, a workforce of around 1,600, and pro forma 2024 sales of $1 7 billion
- Mallinckrodt, Endo Complete Merger to Create Global, Scaled . . .
PRNewswire -- Mallinckrodt plc and Endo, Inc today announced that they have completed their merger to create a global, scaled, diversified therapeutics
- Mallinckrodt Pharmaceuticals - Listening for Needs. Delivering Solutions
About Us Solving complex challenges with a diverse product portfolio Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products
- Welcome to Mallinckrodts Medical Information Portal
This site is an online medical resource intended to provide scientifically accurate, evidence-based, and balanced medical information on Mallinckrodt products
- Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova . . .
Mallinckrodt plc ("Mallinckrodt") today announced the completion of the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses
|
|
|